While the body naturally produces alpha-lipoic acid (ALA), people can boost their levels by making suitable dietary choices, taking supplements, or both
This raises a compelling question: Could the virus (or the immune response to it) increase GLP-1 production or mimic its downstream effects
This work was partially supported by National Natural Science Foundation of China 81872915 (M.-W.W.), 82073904 (M.-W.W.), 81922071 (Y.Z.), 81773792 (D.Y.), 81973373 (D.Y.), and 21704064 (Q.Z.)
When sulforaphane frees Nrf2 to enter the nucleus, it triggers a massive upregulation of the body's endogenous antioxidant network
Patients diagnosed with diabetes are initiating GLP-1 treatment more quickly than ever before Since 2021, the average time between a diabetes diagnosis and the initiation of a GLP-1 therapy has decreased by about one month, underscoring how quickly these drugs have moved to the forefront of care